Introgen`s CEO David Nance Talks to the Wall Street Transcript
... cancer for a minimally toxic cancer therapeutic that could be broadly applied to virtually all tumor types and be administered alone or in combination with conventional cancer treatments....... numerous other Phase I clinical trials for nine different cancers including breast, prostate and brain cancers....
Oct 01 12:58 PM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/bw/011001/11065_1.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines